- Report
- August 2026
- 376 Pages
Global
From €5248EUR$5,850USD£4,486GBP
- Report
- August 2026
- 477 Pages
Global
From €5248EUR$5,850USD£4,486GBP
- Report
- August 2026
- 487 Pages
Global
From €5248EUR$5,850USD£4,486GBP
- Report
- August 2026
- 465 Pages
Global
From €5248EUR$5,850USD£4,486GBP
- Report
- August 2026
- 279 Pages
Global
From €5248EUR$5,850USD£4,486GBP
- Report
- August 2026
- 194 Pages
Global
From €5248EUR$5,850USD£4,486GBP
- Report
- August 2026
- 192 Pages
Global
From €5248EUR$5,850USD£4,486GBP
- Report
- August 2026
- 372 Pages
Global
From €5248EUR$5,850USD£4,486GBP
- Report
- August 2026
- 372 Pages
Global
From €5248EUR$5,850USD£4,486GBP
- Report
- August 2026
- 372 Pages
Global
From €5248EUR$5,850USD£4,486GBP
- Report
- August 2026
- 273 Pages
Global
From €5248EUR$5,850USD£4,486GBP
- Report
- August 2026
- 174 Pages
Global
From €5248EUR$5,850USD£4,486GBP
- Report
- August 2026
- 179 Pages
Global
From €5248EUR$5,850USD£4,486GBP
- Report
- August 2026
- 312 Pages
Global
From €5248EUR$5,850USD£4,486GBP
- Report
- August 2026
- 604 Pages
Global
From €5248EUR$5,850USD£4,486GBP
- Report
- May 2026
- 140 Pages
Global
From €4261EUR$4,750USD£3,643GBP
- Report
- November 2025
- 150 Pages
Global
From €3364EUR$3,750USD£2,876GBP
- Report
- November 2025
- 150 Pages
Global
From €3364EUR$3,750USD£2,876GBP
- Report
- July 2026
- 180 Pages
Global
From €4261EUR$4,750USD£3,643GBP
- Report
- July 2026
- 110 Pages
Global
From €4261EUR$4,750USD£3,643GBP

The Blood Cell market is a subset of the biotechnology industry that focuses on the development of products and services related to the study and manipulation of blood cells. This includes the production of blood cell-based therapeutics, such as monoclonal antibodies, as well as the development of diagnostic tests and treatments for blood-related diseases. Blood cell research is also used to develop treatments for cancer, autoimmune diseases, and other conditions.
The Blood Cell market is a rapidly growing sector of the biotechnology industry, with new products and services being developed to meet the needs of patients and healthcare providers. Companies in this market are focused on developing innovative technologies and treatments to improve patient outcomes and reduce healthcare costs.
Some of the companies in the Blood Cell market include AbbVie, Amgen, AstraZeneca, Biogen, Celgene, Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, and Regeneron Pharmaceuticals. Show Less Read more